Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy After Curative Resection of Non-Small Cell Lung Cancer
NCT00002823Phase 3Completed
- Sponsor
- Gustave Roussy
- Start
- Feb 1995
- Primary completion
- Jan 2001
- Modality
- Small Molecules
- Countries
- 29
01
Overview
Phase 3, randomised, open-label trial of cisplatin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Gustave Roussy. Primary endpoint: Overall Survival. Started Feb 1995; status: completed.
02
Drugs
cisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00002823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002823.